CAPITAL STOCK (Details)	Nov. 15, 2019 USD ($) $ / shares shares	Oct. 31, 2019 $ / shares	Aug. 22, 2019 USD ($) $ / shares shares	Aug. 07, 2019 $ / shares shares	Jan. 25, 2019 USD ($) shares	Dec. 26, 2018 $ / shares shares	Dec. 21, 2018 USD ($) $ / shares shares	Dec. 21, 2019 $ / shares shares	Nov. 01, 2019 $ / shares	Sep. 30, 2019 $ / shares shares	Sep. 30, 2018 $ / shares shares
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock, par value | $ / shares										$ 0.001	$ 0.001
Common stock issued in private placement, net of offering costs (in shares)				100,617
Exercise price of warrants (in dollars per share) | $ / shares				$ 20.00				$ 17.60
Number of common stock issued				100,617
Number of warrants outstanding				143,252						263,592	305,217
Accredited investors
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock issued in private placement, net of offering costs (in shares)			38,704
Number of common stock issued			38,704
Common stock, issue price | $ / shares			$ 10.80
Total Gross Proceeds | $			$ 418,000
Accredited investors, minimum stockholding percentage			5.00%
Subsequent Event
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Reverse stock split		0.025
Common stock, par value | $ / shares	$ 0.001	$ 0.001							$ 0.001
Exercise price of warrants (in dollars per share) | $ / shares	$ 5.60
Offering
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Exercise price of warrants (in dollars per share) | $ / shares										$ 12.00
Offering | Subsequent Event
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock issued in private placement, net of offering costs (in shares)	2,285,000
Number of common stock called by warrants	2,285,000
Number of common shares that each warrant has right to purchase	1
Exercise price of warrants (in dollars per share) | $ / shares	$ 5.25
Public offering price for each share together with warrant | $ / shares	$ 5.25
Additional number of common stock called by warrants	342,750
Warrants exercisable expiration period	45 days
Gross proceeds of offering before underwriter discounts, commissions and other offering expenses | $	$ 12,000,000
Proceeds of offering if underwriters exercise in full their overallotment option | $	13,800,000
Net proceeds from offering after deducting underwriting fees and other expense | $	$ 10,800,000
Minimum exercise price | $ / shares	$ 1.47
Beneficial Ownership Limitation (as a percent)	4.99%
Beneficial Ownership Limitation, at the election of the holder (as a percent)	9.99%
Prior notice period to increase beneficial ownership	61 days
Number of common stock issued	2,285,000
Number of common stock called by warrants	2,285,000
Underwriting Agreement [Member] | Maxim Group Llc [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock issued in private placement, net of offering costs (in shares)							137,500
Number of common stock called by warrants							137,500
Exercise price of warrants (in dollars per share) | $ / shares							$ 20.00
Public offering price for each share together with warrant | $ / shares							$ 20.00
Additional number of common stock called by warrants							20,625
Gross proceeds of offering before underwriter discounts, commissions and other offering expenses | $							$ 2,750,000
Net proceeds from offering after deducting underwriting fees and other expense | $							$ 2,262,000
Minimum exercise price | $ / shares							$ 5.60
Number of common stock issued							137,500
Determinant for number of shares issued on exercise of warrants							0.70
Number of warrants outstanding								68,375
Number of common stock called by warrants							137,500
Number of warrants purchased						20,000
Term of warrants							5 years
Purchase price per warrant (in dollars per warrant) | $ / shares						$ 0.0000004
Underwriting Agreement [Member] | Maxim Group Llc [Member] | Over-Allotment Option [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Number of aggregate common stock issued including exercise of over-allotment option					150,000
Gross amount of common stock and warrants issued including exercise of over-allotment option | $					$ 3,000,000
Net amount of common stock and warrants issued including exercise of over-allotment option | $					$ 2,500,000
Number of common shares issued under underwriters partial exercise of over-allotment option					12,500
Amount of common shares issued under underwriters partial exercise of over-allotment option | $					$ 250,000
Number of warrants issued including exercise of over-allotment option					157,500
Net proceeds from over allotment after deducting underwriting fees and other expense | $					$ 201,000